Skip to content
Oncology Research Hub

Cancer studies

Cancer clinical trials start with a conversation

Oncology Research Hub is a service for people who want to understand cancer clinical trials, whether for themselves or for someone they care for. If you are interested, we connect you with study teams. The first step is a short conversation. It costs nothing, and it places you under no obligation.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed
A laboratory microscope against a dark background
Photo by Vladimir Srajber on Pexels
All locations

Cancer studies in numbers

cancer studies recruiting in the U.S.
3,223
states with a study site
51
cities with a study site
1,597
studies that accept healthy volunteers
254

Source: ClinicalTrials.gov. Data processed .

Find cancer studies near you

These states have the most studies recruiting right now.

Cancer studies recruiting now

As of November 16, 2026, 3,223 cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This is what they have in common.

What they test

  • medications1,850
  • other approaches635
  • procedures558
  • biologics such as vaccines or antibodies425
  • radiation262

A study can test more than one.

Main purpose

  • treating a condition2,051
  • supportive care225
  • diagnosis138
  • how care is delivered73

Phase

  • Early Phase 160
  • Phase 1539
  • Phase 1/2407
  • Phase 2794
  • Phase 2/332
  • Phase 3242
  • Phase 439
  • No phase597
  • Observational513

Studies of devices and behavioral approaches have no phase.

Who runs them

  • university, hospital or other2,153
  • industry913
  • government157

Who they enroll

  • adults (18 to 64)3,178
  • older adults (65 and over)3,074
  • children (under 18)284

254 also accept healthy volunteers.

Where: sites in 51 states. The cities with the most are New York, NY (649), Houston, TX (624), Boston, MA (467), Los Angeles, CA (384), Nashville, TN (344), Chicago, IL (337), Philadelphia, PA (296), St Louis, MO (287).

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 3,223 studies.

Recruiting now, by research area

Recently updated cancer studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Texas Southwestern Medical Center
    Recruiting in
    Dallas, TX · Neptune City, NJ · Pittsburgh, PA · and 2 more U.S. locations
    Registry record
    NCT02468024 · updated
  2. Molecular Analysis of Childhood and Adolescent Melanocytic Lesions

    • Observational
    • Up to age 18
    • All sexes
    Sponsor
    St. Jude Children's Research Hospital
    Recruiting in
    Memphis, TN
    Registry record
    NCT02775643 · updated
  3. Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

    • Phase 2
    • Ages 12 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda, MD
    Registry record
    NCT03258567 · updated
  4. Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Ann Arbor, MI · Aurora, CO · Boise, ID · and 12 more U.S. locations
    Registry record
    NCT04038502 · updated
  5. Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    John Reneau
    Recruiting in
    Columbus, OH
    Registry record
    NCT04848064 · updated
  6. Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston, TX
    Registry record
    NCT05011045 · updated

Source: ClinicalTrials.gov. Data processed .

Not sure which study fits?

Tell a coordinator what you are looking for. They will explain which cancer studies may be worth a closer look and what the next step is. Asking does not commit you to anything.

Call (888) 343-1186

How taking part works

There are four steps. At each one, you choose whether to go on to the next.

  1. Tell us what you are looking for

    You call us or send a short form. Tell us the condition or the kind of study you want to know about, whether it is for you or for a family member.

  2. Talk with a coordinator

    A coordinator tells you which cancer studies may be a match. Any questions you have are answered in plain language.

  3. Meet the study team

    The next step happens only if you want it. The study team goes through the study with you in detail and checks whether you are eligible.

  4. Decide what is right for you

    Joining a study is your decision, always. If you change your mind, you can leave at any time and for any reason.

Research areas

These are the areas of cancer research we help people look into.

  • Breast Cancer studies

    In breast cancer, studies look at investigational medications, at existing therapies used in combination, and at approaches to screening or supportive care.

  • Lung Cancer studies

    Research in lung cancer covers different types and stages of the disease. It examines investigational medications, radiation approaches, and screening methods.

  • Prostate Cancer studies

    Across the stages of prostate cancer, studies evaluate investigational medications, imaging methods, and approaches to monitoring.

  • Melanoma studies

    Melanoma is a form of skin cancer. Research here examines investigational immunotherapies, targeted medications, and combinations.

  • Lymphoma studies

    For Hodgkin and non-Hodgkin lymphoma, studies evaluate investigational medications as well as cell-based approaches.

  • Pancreatic Cancer studies

    In pancreatic cancer, research looks at investigational medications, therapies given in combination, and methods of early detection.

  • Not sure where you fit?

    A coordinator can point you in the right direction. All we need is a little information about what you, or the person you are helping, are looking for.

Why people take part in cancer studies

The reasons for joining a cancer research study differ from person to person. Every one of them is a good thing to talk through before you or your family member decides.

  • Some want a research team to follow their health closely while the study is running.
  • Some want to understand more about a condition they live with.
  • Some want to help researchers answer questions that may shape the care other people receive in the future.

A study is research. It is not treatment, and nobody can promise that taking part will help you personally. For a plain explanation, read what a clinical trial is.

Your safety and your rights come first

No study can enroll a single person until an independent ethics committee has reviewed it. That review comes first. You, or the family member you are reading for, will also have the written details in hand, and nothing is agreed until you do. These pages explain the informed consent process, the review and monitoring each study goes through, and the rights that stay with you from the first day to the last.

Common questions about cancer studies

Does it cost anything to ask about a study?

No. A conversation with Oncology Research Hub costs you nothing. Asking questions, for yourself or for a relative, does not sign anyone up for anything.

Do I have to take part if I call?

No. Every step is yours to decide, including whether to go further. Stopping is possible at any time.

Who decides whether I can join a study?

The study team makes that call, and only once a screening visit is complete. Requirements are set separately for every study. Read about eligibility and screening.

Ask about cancer studies

A coordinator will contact you once you share a few details. Asking, for yourself or for someone you care for, commits you to nothing.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Learn more from independent sources

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call